This interactive5-day courseisfocused on howATMPs can be successfully translated from the laboratory to the clinic, looking specifically into Scientific principles, Manufacturing/CMC, Regulatory pathways, Reimbursement and Patient access. You will learn from real-life scenarios presented by experts in the field, and group assignments. Before attending the course, an 8-hour e-learning course will equip you with the essential knowledge to make the most of the course.
HOW DOES THE COURSE WORK?
This interactive5-day courseisfocused on howATMPs can be successfully translated from the laboratory to the clinic, looking specifically into Scientific principles, Manufacturing/CMC, Regulatory pathways, Reimbursement and Patient access. You will learn from real-life scenarios presented by experts in the field, and group assignments. Before attending the course, an 8-hour e-learning course will equip you with the essential knowledge to make the most of the course.
WHO IS THE COURSE FOR?
The course is designed for rare-disease professionals, including researchers, clinicians, project/programmemanagers and other professionals involved in the ATMP development process.It is suitable for individualsat different career stages from late-stage PhD students toPrincipal Investigators and in different settings (academia, small and medium enterprises,industry,philanthropy).
To support the adaptation of this course to new target groups or geographic areas, we will welcome interested parties to join the course as observer.
What will I learn?
Focusing on Scientific principles, Manufacturing/CMC, Regulatory pathways, Reimbursement and Patient access, the course will meet the following learning objectives, where participants attending the course will be able to:
- Provide an overview of the ATMP development cycle and define the major bottlenecks within the cycle
- Know where to access further knowledge / information to support when developing ATMPs for Rare Disease
ORGANISED BY:
ERDERA & EATRIS
DATE:
1 – 5 June 2026, Utrecht (The Netherlands)